|
Development of Aptamers Neutralizing Antibodies for Demyelinating Diseases
This innovation is research involving the development of aptamers that work to neutralize antibodies which harm the myelin sheath of nerves. The innovation can be a successful treatment for both multiple sclerosis (MS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIPD). These aptamers will be very specific to block certain autoantibodies...
Published: 4/3/2023
|
Inventor(s): May Khanna, Kathleen Rodgers, Maira Soto, Niloufar Mollasalehi
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Small Molecules
|
